China Unveils 2024 Plan to Combat Fraud in Medical Insurance Funds
The National Healthcare Security Administration (NHSA) of China, in conjunction with the Supreme People’s Court,...
Chinese Authorities Launch Special Plan to Rectify Medical Insurance Fraud and Non-Compliance
The National Healthcare Security Administration (NHSA) of China, in collaboration with the Supreme People’s Court,...
China’s NMPA Releases 79th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) in China has released the 79th batch of reference...
AstraZeneca’s Imfinzi Shows Sustained Survival Benefit in Advanced Biliary Tract Cancer Trial
AstraZeneca (AZ; NASDAQ: AZN), a UK-based pharmaceutical and biopharmaceutical company, has this week announced 3-year...
China’s NMPA Launches 2024 Medical Device Industry Standard Revision Plan
The National Medical Products Administration (NMPA) has unveiled the “2024 Medical Device Industry Standard Revision...
Beijing Airdoc Leads RMB 500 Million Joint Venture to Invest in AI-Powered Healthcare
Beijing Airdoc Technology Co., Ltd., a leading artificial intelligence (AI)-powered ophthalmology device company, has announced...
Sirnaomics Receives FDA Feedback on STP705 Development Plan for isSCC Treatment
Sirnaomics Ltd (HKG: 2257), a leading biopharmaceutical company focused on the discovery and development of...
China Medical System’s Opzelura Approved in Macau for Vitiligo Treatment
China Medical System Holdings (CMS; HKG: 0867) has announced that it has received market approval...
Roche China’s Talent and Culture Vice President Chen Yanli Departs for New Opportunities
Roche (SWX: ROG), the Swiss pharmaceutical giant, has announced the departure of Chen Yanli, who...
Easton Pharmaceutical Gets NMPA Nod for Generic Version of Merck KGaA’s Concor
Easton Pharmaceutical Co., Ltd (SHA: 688513), based in Chengdu, has announced that it has received...
Sanofi Advances Phase I/II Trial of Trifunctional NK Cell Engager in Blood Cancers
Sanofi (NASDAQ: SNY), a French multinational pharmaceutical company, has administered the first dose to a...
Roche’s Columvi Meets Overall Survival Endpoint in Diffuse Large B-Cell Lymphoma Trial
Roche (SWX: RO), a leading Swiss pharmaceutical company, has announced that a late-stage clinical trial...
Novartis’s Fabhalta Shows Promise in Phase III IgA Nephropathy Trial
Swiss pharmaceutical giant Novartis (NYSE: NVS) has announced positive preliminary results from a Phase III...
EU Set to Investigate China’s Medical Device Procurement Practices Amid Fairness Concerns
The European Union (EU) is reportedly gearing up to launch an investigation into medical device...
Ningbo Menovo Partners with University of Michigan to Develop GLP-1 Delivery System
Ningbo Menovo Pharmaceutical Co., Ltd (SHA: 603538), a China-based company, has announced a strategic partnership...
Vazyme Partners with Yufang Medical to Boost Alzheimer’s Blood Test Sales Online
Vazyme Biotech Co., Ltd (SHA: 688105), based in China, has entered into a strategic partnership...
Keymed Biosciences Achieves First Dosing in Global Phase III Trial for Claudin 18.2 Targeting ADC
Keymed Biosciences Inc., (HKG: 2162), a biopharmaceutical company based in China, has announced the completion...
89bio Partners with BiBio Biopharma to Build API Facility for Pegozafermin in China
U.S. biotechnology company 89bio (NASDAQ: ETNB) has secured the services of China-based Contract Development and...
Shanghai Electric Group and Siemens Healthineers Unveil Ultramarine Series Medical Imaging Devices
Shanghai Electric Group, a major player in China’s electrical equipment industry, has partnered with Siemens...
JD Healthcare Forges Partnerships with Top Medical Device Firms at CMEF
The China International Medical Equipment Fair (CMEF), which took place last week in Shanghai, was...